Literature DB >> 11774130

Myeloperoxidase-antineutrophil cytoplasmic antibody-associated glomerulonephritis superimposed on biopsy-proven diabetic nephrosclerosis.

Toshiharu Ninomiya1, Hidetoshi Kanai, Makoto Hirakawa, Yoshihide Arimura, Kohsuke Masutani, Minoru Kashiwagi, Sachiko Nakamura, Yuko Koga, Kyoichi Fukuda, Hideki Hirakata.   

Abstract

We present a case of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-associated glomerulonephritis with diabetic nephrosclerosis, diagnosed by serial renal biopsies within a short period. A 78-year-old man with renal insufficiency, who had been diagnosed with diabetic nephrosclerosis by renal biopsy 9 months earlier, was admitted to the hospital for dyspnea and rapid deterioration of renal function. The titer of serum MPO-ANCA was high, and the second renal biopsy confirmed the presence of necrotizing glomerulonephritis with crescents. Methylprednisolone pulse therapy followed by oral administration of prednisolone led to resolution of respiratory symptoms and reversal of MPO-ANCA. Renal function did not improve, however, necessitating hemodialysis. A review of the literature showed several cases of necrotizing glomerulonephritis superimposed on diabetic nephropathy but only a few reported cases of MPO-ANCA glomerulonephritis associated with diabetic nephrosclerosis. Diabetic patients who show rapid deterioration of renal function should undergo renal biopsy to determine the concomitant presence, if any, of other glomerular diseases and to prevent life-threatening systemic involvement. Copyright 2002 by the National Kidney Foundation, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11774130     DOI: 10.1053/ajkd.2002.29925

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  1 in total

1.  Pauci-immune crescentic glomerulonephritis superimposed on diabetic glomerulosclerosis.

Authors:  Samih H Nasr; Vivette D D'Agati; Samar M Said; Michael B Stokes; Gerald B Appel; Anthony M Valeri; Glen S Markowitz
Journal:  Clin J Am Soc Nephrol       Date:  2008-05-28       Impact factor: 8.237

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.